Compounded vs Brand-Name GLP-1s: An Honest Comparison
Compounded semaglutide costs a fraction of the brand. It is also not an FDA-approved product, and the regulatory ground has shifted. Here is the trade-off without the sales pitch.
Medically reviewed by Dr. Adaeze Nwosu, MD
We prescribe both, so we have an obvious interest in how this comparison reads. We are going to lay out the genuine trade-off anyway, including the parts that do not favour the cheaper option.
What compounding actually is
A compounding pharmacy prepares a medication for a specific patient rather than manufacturing a finished product for the general market. Licensed outsourcing facilities operate under FDA oversight and must meet quality standards, but the preparations themselves are not FDA-approved products.
That distinction is the whole conversation. It is not that compounded semaglutide is a different molecule. It is that the finished preparation has not been through the approval process that Wegovy went through.
What you gain
- Cost. Compounded options typically run a fraction of brand cash prices.
- Dose flexibility, since preparations can be made outside fixed pen increments.
- Availability during periods when brand supply has been constrained.
What you give up
- The FDA approval of the finished product, including its manufacturing and stability review.
- Batch-to-batch consistency guarantees that apply to approved products.
- Manufacturer support programmes and, in most cases, any insurance billing.
The regulatory picture has moved
Large-scale compounding of these molecules expanded during the periods when semaglutide and tirzepatide were on the FDA drug shortage list. Once a drug is removed from that list, the allowances that permitted compounding essentially-copies narrow considerably.
This is an area that has changed repeatedly and may change again. Any clinic telling you the situation is settled is either not paying attention or hoping you are not. Ask your provider what their current sourcing is and under what basis they are compounding.
How to judge a compounding pharmacy
Ask whether the facility is a 503B outsourcing facility registered with the FDA, whether it publishes third-party potency and sterility testing, and where the active ingredient is sourced. A clinic that cannot answer those three questions quickly is not one to buy from.
Cheaper is a real advantage. It is not the only variable, and anyone presenting it as the only variable is selling rather than advising.
How we decide with members
If insurance covers a brand product at a manageable cost, that is usually the cleaner route and we will say so. If it does not, and the alternative is no treatment at all, a compounded preparation from a facility we trust is a reasonable option that we will explain in full first.
What we will not do is present the two as equivalent. They are not, and you deserve to make that choice knowing exactly what the difference is.
This article is for general information and is not medical advice. Talk to a licensed clinician about your own situation before starting or stopping any medication.
